Company intelligence / Profile preview
Mineralys Therapeutics
Radnor, Pennsylvania, United Statesmineralystx.com ↗
- Ownership
- Public · MLYS
- Development stage
- Phase 3
01
Overview
Mineralys has completed three successful clinical trials for lorundrostat, including the pivotal Launch-HTN Phase 3 and Advance-HTN Phase 2 trials, which demonstrated significant blood pressure reduction in patients with uncontrolled or resistant hypertension. The 50mg dose achieved a 9.1 mmHg placebo-adjusted reduction in systolic blood pressure at week 6 and an 11.7 mmHg reduction at week 12 in the Phase 3 trial. The Phase 2 trial showed a 7.9 mmHg placebo-adjusted reduction in 24-hour blood pressure monitoring at week 12. Both trials demonstrated favorable safety profiles.
- Therapeutic areas
- PulmonologyCardiovascularNephrology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Mitsubishi Tanabe Pharmaceutical Company
04
Financials
- Market cap
- $2.6B
- Total revenue
- $0
- Enterprise value
- $2B
Beyond the preview
Go deeper on Mineralys Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mineralys Therapeutics.